Bayer | BAYN - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Air Liquide EUR 3.96B 2.05B 2025-12
Akzo Nobel EUR 2.76B 1.14B 2026-03
Alcon AG USD 1.58B 80M 2026-03
Amarin USD 143.56M 12.5M 2026-06
Arkema EUR 1.73B 458.1M 2026-03
AstraZeneca USD 4.89B 2.67B 2026-06
BASF EUR 7.8B 4.71B 2026-06
Bayer EUR 4.29B 1.44B 2026-06
Beiersdorf EUR 1.2B 33M 2025-12
Corteva USD 2.37B 401M 2026-06
Covestro EUR 648M 44M 2025-12
Essilor EUR 3.54B 758M 2025-12
Fresenius EUR 2.06B 752M 2026-03
Fresenius Medical Care EUR 1.06B 177.89M 2026-06
Genmab DKK 1.5B 18M 2026-06
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
GRIFOLS EUR 513M 189M 2026-06
Henkel EUR 2.71B 163M 2025-12
Hikma Pharmaceutical USD 217M 19M 2025-12
Johnson Matthey GBP 542M 49M 2024-06
Linde USD 3.96B 1.1B 2026-03
Lonza CHF 719M 188M 2025-12
Merck EUR 2.74B 415M 2026-03
Novartis USD 7.62B 739M 2026-06
Nutrien USD 921M 144M 2026-06
Philips EUR 1.79B 803M 2026-06
PPG Industries USD 1.52B 53M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
SAP EUR 10.04B 1.83B 2026-03
Solvay EUR 367M 119M 2026-06
UCB EUR 1.57B 1.14B 2024-12
Umicore EUR 1.56B 450.17M 2025-12
Vinci EUR 17.25B 2.18B 2025-12